Comparative analysis of mechanical and bioprosthetic valves after aortic valve replacement

A. M. Borkon, L. M. Soule, K. L. Baughman, H. Aoun, William A Baumgartner, T. J. Gardner, L. Watkins, Vincent L Gott, B. A. Reitz

Research output: Contribution to journalArticle

Abstract

Comparative long-term performance characteristics of Bjork-Shiley mechanical and bioprosthetic valves were analyzed for patients undergoing aortic valve replacement between 1976 and 1981. A total of 419 patients received either a standard Bjork-Shiley (n = 266) or bioprosthetic (porcine, n = 126, or pericardial, n = 27) aortic valve. Cumulative patient follow-up was 1,705 patient-years; the average patient follow-up was 4.1 ± 2.7 years. Survival data were obtained for all but 11 patients (97% complete follow-up) up to 9 years after operation. Survival at 5 years was 81% ± 4% (± standard error) for Bjork-Shiley and for bioprosthetic valve recipients. Valve failure in the Bjork-Shiley group was predominately due to valve-related mortality and did not result from structural failure. Patients with bioprosthetic valves experienced valve failure as a result of prosthetic valve endocarditis and intrinsic valve degeneration. Although patients with bioprostheses experienced a lower incidence of valve-related morbidity than Bjork-Shiley valve recipients (p <0.03), no difference could be demonstrated in the incidence of valve-related mortality or valve failure at 5 years between bioprosthetic and Bjork-Shiley valves. Mortality rate from valve failure was higher for Bjork-Shiley (86%, 12/14) than bioprosthetic valves (36%, 5/14) (p <0.01).

Original languageEnglish (US)
Pages (from-to)20-33
Number of pages14
JournalJournal of Thoracic and Cardiovascular Surgery
Volume94
Issue number1
StatePublished - 1987
Externally publishedYes

Fingerprint

Aortic Valve
Mortality
Bioprosthesis
Survival
Incidence
Endocarditis
Swine
Morbidity

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery

Cite this

Borkon, A. M., Soule, L. M., Baughman, K. L., Aoun, H., Baumgartner, W. A., Gardner, T. J., ... Reitz, B. A. (1987). Comparative analysis of mechanical and bioprosthetic valves after aortic valve replacement. Journal of Thoracic and Cardiovascular Surgery, 94(1), 20-33.

Comparative analysis of mechanical and bioprosthetic valves after aortic valve replacement. / Borkon, A. M.; Soule, L. M.; Baughman, K. L.; Aoun, H.; Baumgartner, William A; Gardner, T. J.; Watkins, L.; Gott, Vincent L; Reitz, B. A.

In: Journal of Thoracic and Cardiovascular Surgery, Vol. 94, No. 1, 1987, p. 20-33.

Research output: Contribution to journalArticle

Borkon, AM, Soule, LM, Baughman, KL, Aoun, H, Baumgartner, WA, Gardner, TJ, Watkins, L, Gott, VL & Reitz, BA 1987, 'Comparative analysis of mechanical and bioprosthetic valves after aortic valve replacement', Journal of Thoracic and Cardiovascular Surgery, vol. 94, no. 1, pp. 20-33.
Borkon, A. M. ; Soule, L. M. ; Baughman, K. L. ; Aoun, H. ; Baumgartner, William A ; Gardner, T. J. ; Watkins, L. ; Gott, Vincent L ; Reitz, B. A. / Comparative analysis of mechanical and bioprosthetic valves after aortic valve replacement. In: Journal of Thoracic and Cardiovascular Surgery. 1987 ; Vol. 94, No. 1. pp. 20-33.
@article{bf67436dac294030a4156d40d701ae17,
title = "Comparative analysis of mechanical and bioprosthetic valves after aortic valve replacement",
abstract = "Comparative long-term performance characteristics of Bjork-Shiley mechanical and bioprosthetic valves were analyzed for patients undergoing aortic valve replacement between 1976 and 1981. A total of 419 patients received either a standard Bjork-Shiley (n = 266) or bioprosthetic (porcine, n = 126, or pericardial, n = 27) aortic valve. Cumulative patient follow-up was 1,705 patient-years; the average patient follow-up was 4.1 ± 2.7 years. Survival data were obtained for all but 11 patients (97{\%} complete follow-up) up to 9 years after operation. Survival at 5 years was 81{\%} ± 4{\%} (± standard error) for Bjork-Shiley and for bioprosthetic valve recipients. Valve failure in the Bjork-Shiley group was predominately due to valve-related mortality and did not result from structural failure. Patients with bioprosthetic valves experienced valve failure as a result of prosthetic valve endocarditis and intrinsic valve degeneration. Although patients with bioprostheses experienced a lower incidence of valve-related morbidity than Bjork-Shiley valve recipients (p <0.03), no difference could be demonstrated in the incidence of valve-related mortality or valve failure at 5 years between bioprosthetic and Bjork-Shiley valves. Mortality rate from valve failure was higher for Bjork-Shiley (86{\%}, 12/14) than bioprosthetic valves (36{\%}, 5/14) (p <0.01).",
author = "Borkon, {A. M.} and Soule, {L. M.} and Baughman, {K. L.} and H. Aoun and Baumgartner, {William A} and Gardner, {T. J.} and L. Watkins and Gott, {Vincent L} and Reitz, {B. A.}",
year = "1987",
language = "English (US)",
volume = "94",
pages = "20--33",
journal = "Journal of Thoracic and Cardiovascular Surgery",
issn = "0022-5223",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Comparative analysis of mechanical and bioprosthetic valves after aortic valve replacement

AU - Borkon, A. M.

AU - Soule, L. M.

AU - Baughman, K. L.

AU - Aoun, H.

AU - Baumgartner, William A

AU - Gardner, T. J.

AU - Watkins, L.

AU - Gott, Vincent L

AU - Reitz, B. A.

PY - 1987

Y1 - 1987

N2 - Comparative long-term performance characteristics of Bjork-Shiley mechanical and bioprosthetic valves were analyzed for patients undergoing aortic valve replacement between 1976 and 1981. A total of 419 patients received either a standard Bjork-Shiley (n = 266) or bioprosthetic (porcine, n = 126, or pericardial, n = 27) aortic valve. Cumulative patient follow-up was 1,705 patient-years; the average patient follow-up was 4.1 ± 2.7 years. Survival data were obtained for all but 11 patients (97% complete follow-up) up to 9 years after operation. Survival at 5 years was 81% ± 4% (± standard error) for Bjork-Shiley and for bioprosthetic valve recipients. Valve failure in the Bjork-Shiley group was predominately due to valve-related mortality and did not result from structural failure. Patients with bioprosthetic valves experienced valve failure as a result of prosthetic valve endocarditis and intrinsic valve degeneration. Although patients with bioprostheses experienced a lower incidence of valve-related morbidity than Bjork-Shiley valve recipients (p <0.03), no difference could be demonstrated in the incidence of valve-related mortality or valve failure at 5 years between bioprosthetic and Bjork-Shiley valves. Mortality rate from valve failure was higher for Bjork-Shiley (86%, 12/14) than bioprosthetic valves (36%, 5/14) (p <0.01).

AB - Comparative long-term performance characteristics of Bjork-Shiley mechanical and bioprosthetic valves were analyzed for patients undergoing aortic valve replacement between 1976 and 1981. A total of 419 patients received either a standard Bjork-Shiley (n = 266) or bioprosthetic (porcine, n = 126, or pericardial, n = 27) aortic valve. Cumulative patient follow-up was 1,705 patient-years; the average patient follow-up was 4.1 ± 2.7 years. Survival data were obtained for all but 11 patients (97% complete follow-up) up to 9 years after operation. Survival at 5 years was 81% ± 4% (± standard error) for Bjork-Shiley and for bioprosthetic valve recipients. Valve failure in the Bjork-Shiley group was predominately due to valve-related mortality and did not result from structural failure. Patients with bioprosthetic valves experienced valve failure as a result of prosthetic valve endocarditis and intrinsic valve degeneration. Although patients with bioprostheses experienced a lower incidence of valve-related morbidity than Bjork-Shiley valve recipients (p <0.03), no difference could be demonstrated in the incidence of valve-related mortality or valve failure at 5 years between bioprosthetic and Bjork-Shiley valves. Mortality rate from valve failure was higher for Bjork-Shiley (86%, 12/14) than bioprosthetic valves (36%, 5/14) (p <0.01).

UR - http://www.scopus.com/inward/record.url?scp=0023278904&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023278904&partnerID=8YFLogxK

M3 - Article

C2 - 3600005

AN - SCOPUS:0023278904

VL - 94

SP - 20

EP - 33

JO - Journal of Thoracic and Cardiovascular Surgery

JF - Journal of Thoracic and Cardiovascular Surgery

SN - 0022-5223

IS - 1

ER -